Subclinical thyrotoxicosis and the heart

Thyroid

Volumn 12, Issue 6, 2002, Pages 495-499

  Burmeister, Lynn A ^a,b   Flores, Angel ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Tri State Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIOTHYRONINE; THYROID HORMONE;

BLOOD; CARDIOMYOPATHY; CARDIOVASCULAR FUNCTION; DRUG EFFECT; EXERCISE TOLERANCE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE EXTRASYSTOLE; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; THYROTOXICOSIS; CLINICAL FEATURE; EXERCISE; HEART FUNCTION; HEMODYNAMIC MONITORING; MORPHOLOGY; PATHOGENESIS; PRIORITY JOURNAL;

CARDIOMYOPATHIES; CARDIOVASCULAR PHYSIOLOGY; EXERCISE TOLERANCE; HEMODYNAMIC PROCESSES; HUMANS; THYROTOXICOSIS; THYROTROPIN; THYROXINE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PREMATURE COMPLEXES; HEMODYNAMICS; HUMAN; MYOCARDIAL DISEASES;

EID: 0036018274     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072502760143872     Document Type: Review

References (38)

1. Measurement of thyrotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay
2. Subclinical thyrotoxicosis
3. Subclinical hyperthyroidism
4. Serum TSH measurement: A 1990 status report
5. Radioimmunoassay of human thyrotropin: Analytical and clinical developments
6. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement
7. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders
8. Subclinical hyperthyroidism
9. Low TSH levels in nursing home residents not taking thyroid hormones
10. Non-activated (apathetic) type of hyperthyroidism
11. Hyperthyroidism in patients over the age of 60 years
12. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation
13. Graves' disease. Influence of age on clinical findings
14. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism
15. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons
16. The many causes of subclinical hyperthyroidism
17. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine
18. Control of adrenergic overactivity by β-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine
19. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: Beneficial effect of β-blockade
20. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine
21. Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function
22. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients
23. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: Effect of individual dose tailoring
24. Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: Response to specific antithyroid therapy
25. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion
26. Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: A case for "tissue thyrotoxicosis
27. Morbidity in patients on L-thyroxine: A comparison of those with a normal TSH to those with a suppressed TSH
28. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis
29. How useful is thyroid function testing in patients with recent-onset atrial fibrillation?
30. Minimal cardiac effects in asymptomatic athyreotic patients clinically treated with thyrotropin-suppressive doses of L-thyroxine
31. Blood pressure and peripheral circulation
32. Occult thyrotoxicosis: A correctable cause of "idiopathic" atrial fibrillation
33. Occult thyrotoxicosis in patients with chronic and paroxysmal isolated atrial fibrillation
34. Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status
35. Subclinical hyperthyroidism: Possible danger of overzealous thyroxine replacement therapy
36. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH
37. Thyroid hormone in the treatment of thyroid cancer: Rationale and regimen differentiated